Compare Hims and Hers Health Inc (HIMS) vs iShares iBoxx $ Inv Grade Corporate Bond ETF (LQD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs iShares iBoxx $ Inv Grade Corporate Bond ETF — how do they compare? Hims and Hers Health Inc trades at $29.33 (market cap $6.55B), while iShares iBoxx $ Inv Grade Corporate Bond ETF trades at $102.41 (market cap $28.50B). The key difference: iShares iBoxx $ Inv Grade Corporate Bond ETF is far larger — about 4.4× Hims and Hers Health Inc's market cap, and Hims and Hers Health Inc is trading nearer its 52-week high, iShares iBoxx $ Inv Grade Corporate Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and iShares iBoxx $ Inv Grade Corporate Bond ETF for 125 Days on average.
| HIMS | LQD | |
|---|---|---|
Market Cap | $6.55B | $28.50B |
Volume | 14,842,814 | 37,320,110 |
Sector | Health | Fixed Income |
52-Week High | $62.76 | $112.91 |
52-Week Low | $14.52 | $101.83 |
Typical Hold Time | 21 Days | 125 Days |
Enterprise Value | $7.25B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health (HIMS) trades at $29.38, down 0.54% on the day, amid a bearish technical signal and mixed earnings history. The company reported revenue of $2.35 billion in 2025 with a net income of $128.37 million, but 2026 projections show a net loss of $142 million. Valuation ratios are elevated with a P/E of 57.14 and EV/EBITDA of 205.86. Recent news highlights multiple securities class action lawsuits filed against the company, creating investor uncertainty.
The outlook is cautious due to profitability concerns and legal risks. Analyst consensus is a Hold with a $32.17 price target, suggesting limited upside. Key risks include ongoing litigation, negative profit margins, and high valuation multiples. Investment appeal hinges on the company's ability to return to profitability and navigate regulatory challenges.
LQD, the iShares iBoxx $ Investment Grade Corporate Bond ETF, trades at $102.295, up slightly by 0.17% on the day. The technical outlook is bearish, with moving averages signaling selling pressure, while oscillators are neutral. Recent news highlights a significant increase in short interest and a challenging environment for bonds due to rising yields. The fund maintains a 4.8% yield, with recent dividend payments, but faces headwinds from higher interest rates impacting corporate borrowing costs.
The outlook for LQD is cautious amid a rising rate environment, which pressures bond prices. Investment opportunities lie in its high-quality corporate bond portfolio and steady yield, but risks include further yield increases and economic slowdowns affecting credit quality. Investors should weigh the fund's income generation against interest rate sensitivity and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About iShares iBoxx $ Inv Grade Corporate Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in fixed income securities of the types included in the underlying index that the advisor believes will help the fund track the underlying index. The underlying index is designed to provide a broad representation of the US dollar-denominated liquid investment-grade corporate bond market.
Read more on LQD →
